- Bedoelde u
- arise, kevin k
Zoekresultaten - 35 results
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Lemy, Anne; Maria Goossens; I Desombere; Michiels, Johan; Vandevenne, Marylène; Heyndrickx, Leo; Ariën, Kevin K; Matagne, André; Ackerman, Margaret E; Le Moine, Alain; Marchant, Arnaud Source: Am ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; Desombere, Isabelle; Ariën, Kevin K; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Keywords: Adult ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
I Desombere; Kevin K. Ariën; Maria Goossens Source: PLOS Global Public Health, Volume 2, Issue 12 (2022) Keywords: COVID-19; fractional dose; reduced dose; mRNA vaccination; non-inferiority; SARS-CoV-2 Abstract: ...
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
Lisa Verheggen; Debbie Le Blon; Bart Peeters; Maria Goossens; Pieter Pannus; Ariën, Kevin K; Sébastien Anguille; Annelies Janssens; Hans Prenen; Evelien L J Smits; Christof Vulsteke; Eva Lion; Peeters, ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Publication Type: Peer reviewed scientific article Authors: Frédéric Baron; Lorenzo Canti; Ariën, Kevin K; Delphine Kemlin; I Desombere; Margaux Gerbaux; Pieter Pannus; Yves Beguin; Arnaud Marchant; ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Vanhoutte; Bart Peeters; Silke Raats; Isolde Van der Massen; Sven De Keersmaecker; Yana Debie; Manon Huizing; Pieter Pannus; Kristof Y Neven; Ariën, Kevin K; Geert A Martens; Marc Van den Bulcke; Ella Roelant; ...
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Publication Type: Peer reviewed scientific article Authors: Lorenzo Canti; Ariën, Kevin K; I Desombere; Stéphanie Humblet-Baron; Pieter Pannus; Heyndrickx, Leo; Aurélie Henry; Sophie Servais; ...
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:
Marcq, Elly; Verheggen, Lisa; Le Blon, Debbie; Peeters, Bart; Maria Goossens; Pannus, Pieter; Ariën, Kevin K.; Anguille, Sébastien; Janssens, Annelies; Prenen, Hans; Smits, Evelien L.J.; Vulsteke, ...
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
Publication Type: Peer reviewed scientific article Authors: Ariën, Kevin K; Heyndrickx, Leo; Johan Michiels; Katleen Vereecken; Kurt Van Lent; Sandra Coppens; Betty Willems; Pieter Pannus; Geert ...
Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.
Publication Type: Peer reviewed scientific article Authors: Alena Moerman; Kris Vernelen; Bernard China; Arnaud Capron; Dorien Van Den Bossche; Joachim Mariën; Ariën, Kevin K; Van Acker, Jos; ...